3C Therapeutics Inc.
$140,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program
EF 2026-2027
Canada
This project will develop, screen, and validate kinase-targeting degraders conjugated to non-antibody delivery moieties to inform antibody-directed optimization of Degrader-Antibody Conjugates, enabli...